{
    "eid": "2-s2.0-85123586706",
    "title": "Post-treatment anti-Mullerian hormone (AMH) levels predict long-term ovarian dysfunction in women with hematological malignancies",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "AMH",
        "chemotherapy",
        "fertility",
        "hematologic malignancies",
        "infertility",
        "leukemia",
        "lymphoma",
        "menstruation"
    ],
    "authors": [
        "Sunisa Kongkiatkamon",
        "Anothai Chintabanyat",
        "Chantana Polprasert",
        "Noppacharn Uaprasert",
        "Ponlapat Rojnuckarin"
    ],
    "citedby-count": 2,
    "ref-count": 34,
    "ref-list": [
        "Long-term survivors of childhood, adolescent and young adult non-Hodgkin lymphoma",
        "Improvements in outcome of childhood acute lymphoblastic leukaemia (ALL) in the UK - a success story of modern medicine through successive UKALL trials and international collaboration",
        "Cancer statistics, 2020",
        "Fertility issues in patients with hematologic malignancies",
        "Ovarian reserve in women treated for acute lymphocytic leukemia or acute myeloid leukemia with chemotherapy, but not stem cell transplantation",
        "Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study",
        "Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients",
        "Chemotherapy-induced ovarian failure: manifestations and management",
        "The risk of premature menopause induced by chemotherapy for early breast cancer",
        "Management of primary ovarian insufficiency symptoms in survivors of childhood and adolescent cancer",
        "Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review",
        "Can anti-M\u00fcllerian hormone Be a reliable biomarker for assessing ovarian function in women postchemotherapy?",
        "Low serum concentrations of anti-M\u00fcllerian hormone are common in 53 female childhood cancer survivors",
        "Transduction pathway of anti-M\u00fcllerian hormone, a sex-specific member of the TGF-beta family",
        "Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function",
        "Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary",
        "Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary",
        "Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3",
        "Biomarkers of ovarian reserve in childhood and adolescence: A systematic review",
        "Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma\u2013evaluation by using antim\u00fcllerian hormone and retrieved oocytes",
        "Anti-M\u00fcllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results",
        "Predicting chemotherapy-induced menopause using baseline and post-chemotherapy anti-M\u00fcllerian hormone levels: results of a pilot study",
        "Anti-m\u00fcllerian hormone as a sensitive marker of ovarian function in young cancer survivors",
        "Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for hodgkin's lymphoma during childhood",
        "Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies",
        "Anti-m\u00fcllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies",
        "Radiation-induced ovarian follicle loss occurs without overt stromal changes",
        "Chemotherapy-induced damage to ovary: mechanisms and clinical impact",
        "Assessment of the ovarian reserve with anti-M\u00fcllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding",
        "Updated clinical outcomes of hematopoietic stem cell transplantation using myeloablative total body irradiation with ovarian shielding to preserve fertility",
        "Assessment of the ovarian reserve with anti-M\u00fcllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding",
        "Sex differences in fertility-related information received by young adult cancer survivors",
        "Reproductive health in Southeast Asian women: current situation and the influence factors",
        "Experiencing reproductive concerns as a female cancer survivor is associated with depression"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Ratchadapisek somphot Endowment Fund"
    ]
}